Position in ALKS
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$419
New position
Shares Held
8
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#408
of 421 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cedar Mountain Advisors, LLC holds $100,046 across 11 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
2,954 | $46,909 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
299 | $14,133 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
22 | $11,920 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
460 | $11,320 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
183 | $8,511 | |
| 6 | PRGO |
PERRIGO Co plc
|
469 | $4,872 | |
| 7 | ZTS |
Zoetis Inc.
|
22 | $1,580 | |
| 8 | ALKS |
Alkermes plc.
This page
|
8 | $419 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419 | 8 | Shares | Sole | 2026-07-02 | |
| No filing history on record for this holder in this stock. | ||||||